NOVAVAX COVID-19 VACCINE, ADJUVANTED- nvx-cov2373 injection, suspension
Suspension for intramuscular injection
Multi-dose vial (10 doses of 0.5 mL)
Record date/time of first use:
Novavax, Inc., Gaithersburg, MD 20878
10 Multi-Dose Vials
(each vial contains 10 doses of 0.5 mL)
COVID-19 Vaccine, Adjuvanted
For use under Emergency Use Authorization
| NOVAVAX COVID-19 VACCINE, ADJUVANTED |
nvx-cov2373 injection, suspension
|Labeler — Novavax Inc. (808837520)|
|Registrant — Novavax Inc. (808837520)|
Revised: 04/2021 Novavax Inc.
VxLabels.com provides trustworthy package insert and label information about marketed drugs and vaccines as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by VxLabels.com. Every individual vaccine label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.